Variant report

Variant	rs10137076
Chromosome Location	chr14:34966669-34966670
allele	A/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:20)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:20 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr14:34932436..34934680-chr14:34965867..34967830,2	K562	blood:
2	chr14:34800596..34801300-chr14:34965892..34967188,3	MCF-7	breast:
3	chr14:34918625..34921655-chr14:34965491..34967777,3	MCF-7	breast:
4	chr14:34800908..34801526-chr14:34966566..34967258,2	MCF-7	breast:
5	chr14:34966374..34968147-chr14:35008912..35011090,2	MCF-7	breast:
6	chr14:34959614..34962811-chr14:34966236..34969041,3	K562	blood:
7	chr14:34965733..34968231-chr14:35022336..35025245,2	MCF-7	breast:
8	chr14:34952643..34954942-chr14:34966507..34969083,2	MCF-7	breast:
9	chr14:34925027..34927369-chr14:34965099..34966912,2	K562	blood:
10	chr14:34927994..34930347-chr14:34965334..34966847,2	K562	blood:
11	chr14:34950779..34952315-chr14:34964739..34966921,2	MCF-7	breast:
12	chr14:34799548..34803609-chr14:34964477..34969425,6	MCF-7	breast:
13	chr14:34928753..34932995-chr14:34963537..34968945,14	MCF-7	breast:
14	chr14:34957508..34960404-chr14:34964346..34966873,2	K562	blood:
15	chr14:34830829..34832701-chr14:34965153..34968151,2	MCF-7	breast:
16	chr14:34824767..34827371-chr14:34965851..34967929,2	MCF-7	breast:
17	chr14:34926801..34930347-chr14:34965269..34966847,3	K562	blood:
18	chr14:34964955..34967907-chr14:34973617..34975342,2	MCF-7	breast:
19	chr14:34947380..34950273-chr14:34964851..34967790,4	MCF-7	breast:
20	chr14:34930215..34933464-chr14:34966414..34969338,4	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000129521	Chromatin interaction
ENSG00000165389	Chromatin interaction
ENSG00000129518	Chromatin interaction

Extended variants
information (count: 22 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:8)

rs_ID	r²[population]
rs10130000	1.00[CEU][hapmap]
rs10143471	0.85[AMR][1000 genomes]
rs10147550	1.00[CEU][hapmap];0.92[YRI][hapmap];0.92[AFR][1000 genomes];0.85[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs11844057	0.85[AMR][1000 genomes]
rs4982172	1.00[CEU][hapmap]
rs4982173	1.00[CEU][hapmap]
rs4982186	1.00[EUR][1000 genomes]
rs8004728	1.00[CEU][hapmap]

Variant overlapped rSNPs/rCNVs (count:14 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1040980	chr14:34345018-35255592	Strong transcription Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	109 gene(s)	inside rSNPs	diseases
2	nsv1051104	chr14:34592378-35007083	Flanking Bivalent TSS/Enh Enhancers Weak transcription Strong transcription Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	16 gene(s)	inside rSNPs	diseases
3	nsv949738	chr14:34616331-34990688	Strong transcription Flanking Active TSS Enhancers Weak transcription Active TSS ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases
4	nsv564192	chr14:34725233-34996507	Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	13 gene(s)	inside rSNPs	diseases
5	nsv564193	chr14:34728127-35000188	Enhancers Flanking Active TSS Weak transcription Strong transcription Active TSS ZNF genes & repeats Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	13 gene(s)	inside rSNPs	diseases
6	nsv528989	chr14:34744426-34998705	Enhancers Weak transcription Strong transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	13 gene(s)	inside rSNPs	diseases
7	nsv1054949	chr14:34834260-34992049	Weak transcription Enhancers Flanking Active TSS Active TSS Strong transcription Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	13 gene(s)	inside rSNPs	diseases
8	nsv542025	chr14:34834260-34992049	Strong transcription Enhancers Weak transcription Genic enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	13 gene(s)	inside rSNPs	diseases
9	nsv1050218	chr14:34851521-34969433	Enhancers Flanking Active TSS Weak transcription Strong transcription Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	13 gene(s)	inside rSNPs	diseases
10	nsv1048369	chr14:34886956-34974774	Strong transcription Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	13 gene(s)	inside rSNPs	diseases
11	nsv901600	chr14:34895977-35010041	Weak transcription Enhancers Active TSS Strong transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	16 gene(s)	inside rSNPs	diseases
12	nsv1037857	chr14:34943388-35007724	Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Active TSS Active TSS Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	8 gene(s)	inside rSNPs	diseases
13	nsv542026	chr14:34943388-35007724	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	8 gene(s)	inside rSNPs	diseases
14	nsv1048408	chr14:34958352-35255592	Weak transcription Strong transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	63 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:80 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:34965200-34967400	Enhancers	Fetal Muscle Leg	muscle
2	chr14:34965200-34967600	Enhancers	HMEC	breast
3	chr14:34965400-34967000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
4	chr14:34965400-34967200	Flanking Active TSS	A549	lung
5	chr14:34965400-34967600	Enhancers	Esophagus	oesophagus
6	chr14:34965400-34968000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
7	chr14:34965400-34968000	Enhancers	Fetal Muscle Trunk	muscle
8	chr14:34965400-34968200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
9	chr14:34965600-34967000	Enhancers	H9 Cell Line	embryonic stem cell
10	chr14:34965600-34967000	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
11	chr14:34965600-34967000	Enhancers	iPS-15b Cell Line	embryonic stem cell
12	chr14:34965600-34967000	Enhancers	Stomach Mucosa	stomach
13	chr14:34965600-34967200	Enhancers	Psoas Muscle	Psoas
14	chr14:34965600-34967200	Flanking Active TSS	Hela-S3	cervix
15	chr14:34965600-34967600	Enhancers	NHLF	lung
16	chr14:34965600-34967800	Enhancers	Fetal Stomach	stomach
17	chr14:34965800-34966800	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
18	chr14:34965800-34967000	Enhancers	iPS-18 Cell Line	embryonic stem cell
19	chr14:34965800-34967000	Enhancers	iPS-20b Cell Line	embryonic stem cell
20	chr14:34965800-34967000	Enhancers	HSMM	muscle
21	chr14:34965800-34967000	Enhancers	HUVEC	blood vessel
22	chr14:34965800-34967200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
23	chr14:34965800-34967200	Enhancers	Breast Myoepithelial Primary Cells	Breast
24	chr14:34965800-34967200	Enhancers	Colon Smooth Muscle	Colon
25	chr14:34965800-34967200	Enhancers	Placenta	Placenta
26	chr14:34966000-34966800	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
27	chr14:34966000-34966800	Flanking Active TSS	Brain Anterior Caudate	brain
28	chr14:34966000-34966800	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
29	chr14:34966000-34966800	Flanking Active TSS	K562	blood
30	chr14:34966000-34967000	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
31	chr14:34966000-34967000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
32	chr14:34966000-34967000	Enhancers	HUES64 Cell Line	embryonic stem cell
33	chr14:34966000-34967000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
34	chr14:34966000-34967000	Enhancers	Brain Hippocampus Middle	brain
35	chr14:34966000-34967000	Enhancers	Placenta Amnion	Placenta Amnion
36	chr14:34966000-34967000	Flanking Active TSS	NHEK	skin
37	chr14:34966000-34967200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
38	chr14:34966000-34967600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
39	chr14:34966000-34967800	Enhancers	Fetal Intestine Large	intestine
40	chr14:34966200-34966800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
41	chr14:34966200-34966800	Weak transcription	Fetal Lung	lung
42	chr14:34966200-34967000	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
43	chr14:34966200-34967200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
44	chr14:34966200-34967200	Enhancers	Ovary	ovary
45	chr14:34966400-34966800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
46	chr14:34966400-34966800	Enhancers	HUES48 Cell Line	embryonic stem cell
47	chr14:34966400-34966800	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
48	chr14:34966400-34966800	Flanking Active TSS	Muscle Satellite Cultured Cells	--
49	chr14:34966400-34966800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
50	chr14:34966400-34966800	Active TSS	Rectal Mucosa Donor 29	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links